Search Results
You are looking at 21 - 22 of 22 items for
- Author: J. MOORE x
- Refine by access: All content x
Search for other papers by Helen E MacLean in
Google Scholar
PubMed
Search for other papers by Alison J Moore in
Google Scholar
PubMed
Search for other papers by Stephen A Sastra in
Google Scholar
PubMed
Search for other papers by Howard A Morris in
Google Scholar
PubMed
Department of Medicine, Hanson Institute, Department of Endocrinology, ANZAC Research Institute, University of Melbourne, Austin Health, Heidelberg, Victoria 3084, Australia
Search for other papers by Ali Ghasem-Zadeh in
Google Scholar
PubMed
Search for other papers by Kesha Rana in
Google Scholar
PubMed
Search for other papers by Anna-Maree Axell in
Google Scholar
PubMed
Search for other papers by Amanda J Notini in
Google Scholar
PubMed
Search for other papers by David J Handelsman in
Google Scholar
PubMed
Department of Medicine, Hanson Institute, Department of Endocrinology, ANZAC Research Institute, University of Melbourne, Austin Health, Heidelberg, Victoria 3084, Australia
Search for other papers by Ego Seeman in
Google Scholar
PubMed
Search for other papers by Jeffrey D Zajac in
Google Scholar
PubMed
Search for other papers by Rachel A Davey in
Google Scholar
PubMed
We used our genomic androgen receptor (AR) knockout (ARKO) mouse model, in which the AR is unable to bind DNA to: 1) document gender differences between males and females; 2) identify the genomic (DNA-binding-dependent) AR-mediated actions in males; 3) determine the contribution of genomic AR-mediated actions to these gender differences; and 4) identify physiological genomic AR-mediated actions in females. At 9 weeks of age, control males had higher body, heart and kidney mass, lower spleen mass, and longer and larger bones compared to control females. Compared to control males, ARKO males had lower body and kidney mass, higher splenic mass, and reductions in cortical and trabecular bone. Deletion of the AR in ARKO males abolished the gender differences in heart and cortical bone. Compared with control females, ARKO females had normal body weight, but 14% lower heart mass and heart weight/body weight ratio. Relative kidney mass was also reduced, and relative spleen mass was increased. ARKO females had a significant reduction in cortical bone growth and changes in trabecular architecture, although with no net change in trabecular bone volume. In conclusion, we have shown that androgens acting via the genomic AR signaling pathway mediate, at least in part, the gender differences in body mass, heart, kidney, spleen, and bone, and play a physiological role in the regulation of cardiac, kidney and splenic size, cortical bone growth, and trabecular bone architecture in females.
Department of Sciences, University of British Columbia, Vancouver, Canada
Search for other papers by Celia Siu in
Google Scholar
PubMed
Search for other papers by Sam Wiseman in
Google Scholar
PubMed
Search for other papers by Sitanshu Gakkhar in
Google Scholar
PubMed
Search for other papers by Alireza Heravi-Moussavi in
Google Scholar
PubMed
Search for other papers by Misha Bilenky in
Google Scholar
PubMed
Search for other papers by Annaick Carles in
Google Scholar
PubMed
Search for other papers by Thomas Sierocinski in
Google Scholar
PubMed
Search for other papers by Angela Tam in
Google Scholar
PubMed
Search for other papers by Eric Zhao in
Google Scholar
PubMed
Search for other papers by Katayoon Kasaian in
Google Scholar
PubMed
Search for other papers by Richard A Moore in
Google Scholar
PubMed
Search for other papers by Andrew J Mungall in
Google Scholar
PubMed
Search for other papers by Blair Walker in
Google Scholar
PubMed
Search for other papers by Thomas Thomson in
Google Scholar
PubMed
Department of Medical Genetics, University of British Columbia, Vancouver, Canada
Search for other papers by Marco A Marra in
Google Scholar
PubMed
Department of Microbiology & Immunology, Michael Smith Laboratories, University of British Columbia, Vancouver, Canada
Search for other papers by Martin Hirst in
Google Scholar
PubMed
Department of Medical Genetics, University of British Columbia, Vancouver, Canada
Department of Molecular Biology & Biochemistry, Simon Fraser University, Burnaby, Canada
Search for other papers by Steven J M Jones in
Google Scholar
PubMed
The thyroid gland, necessary for normal human growth and development, functions as an essential regulator of metabolism by the production and secretion of appropriate levels of thyroid hormone. However, assessment of abnormal thyroid function may be challenging suggesting a more fundamental understanding of normal function is needed. One way to characterize normal gland function is to study the epigenome and resulting transcriptome within its constituent cells. This study generates the first published reference epigenomes for human thyroid from four individuals using ChIP-seq and RNA-seq. We profiled six histone modifications (H3K4me1, H3K4me3, H3K27ac, H3K36me3, H3K9me3, H3K27me3), identified chromatin states using a hidden Markov model, produced a novel quantitative metric for model selection and established epigenomic maps of 19 chromatin states. We found that epigenetic features characterizing promoters and transcription elongation tend to be more consistent than regions characterizing enhancers or Polycomb-repressed regions and that epigenetically active genes consistent across all epigenomes tend to have higher expression than those not marked as epigenetically active in all epigenomes. We also identified a set of 18 genes epigenetically active and consistently expressed in the thyroid that are likely highly relevant to thyroid function. Altogether, these epigenomes represent a powerful resource to develop a deeper understanding of the underlying molecular biology of thyroid function and provide contextual information of thyroid and human epigenomic data for comparison and integration into future studies.